Fullerenol - Properties and applications in biomedical sciences;Fulerenol - Właściwości i zastosowanie w naukach biomedycznych

Postepy Higieny i Medycyny Doswiadczalnej

Volumn 67, Issue , 2013, Pages 859-871

  Grȩbowski, Jacek ^a   Kaźmierska, Paulina ^a   Krokosz, Anita ^a  

^a UNIVERSITY OF LODZ   (Poland)

Author keywords

Fullerenol; Nanomedicine; Oxidative stress

Indexed keywords

ANTINEOPLASTIC AGENT; DIAGNOSTIC AGENT; FULLERENE DERIVATIVE; FULLERENOL; NANOMATERIAL; NEUROPROTECTIVE AGENT; PROTECTIVE AGENT;

ANIMAL; ARTICLE; CELL DEATH; CHEMISTRY; DOSE RESPONSE; DRUG EFFECT; HUMAN; NERVE CELL;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL DEATH; DOSE-RESPONSE RELATIONSHIP, DRUG; FULLERENES; HUMANS; NANOSTRUCTURES; NEURONS; NEUROPROTECTIVE AGENTS; PROTECTIVE AGENTS;

EID: 84892585360     PISSN: 00325449     EISSN: 17322693     Source Type: Journal    
DOI: 10.5604/17322693.1063743     Document Type: Article

References (121)

1. Amadoruge P. C., Barnham K. J.: Alzheimer's disease and metals: a review of the involvement of cellular membrane receptors in metallosignalling. Int. J. Alzheimers Dis., 2011;2011:542043
2. Anderson R., Barron A. R.: Reaction of hydroxyfullerene with metal salts: a route to remediation and immobilization. J. Am. Chem. Soc., 2005;127:10458-10459
3. Anderson S. A., Lee K. K., Frank J. A.: Gadolinium-fullerenol as a paramagnetic contrast agent for cellular imaging. Invest. Radiol., 2006;41:332-338
4. Assemi S., Tadjiki S., Donose B. C., Nguyen A. V., Miller J. D.: Aggregation of fullerol C60 (OH) 24 nanoparticles as revealed using flow fieldflow fractionation and atomic force microscopy. Langmuir, 2010;26:16063-16070
5. Balu M., Sangeetha P., Haripriya D., Panneerselvam C.: Rejuvenation of antioxidant system in central nervous system of aged rats by grape seed extract. Neurosci. Lett., 2005;383:295-300
6. Bartosz G.: Druga twarz tlenu. Wydawnictwo Naukowe PWN, 2003; Warszawa
7. Ben-Shachar D., Riederer P., Youdim M. B.: Iron-melanin interaction and lipid peroxidation: implications for Parkinson's disease. J. Neurochem., 1991;57:1609-1614
8. Beretta G. L., Zunino F.: Molecular mechanisms of anthracycline activity. Top Curr. Chem., 2008;283:1-19
9. Bernat R.: Wskaźniki stresu oksydacyjnego mózgu po dokomorowej infuzji endotoksyny - efekt wpływu adrenergicznego. Now. Lek., 2000;69:58-70
10. Bogdanović V., Stankov K., Icević I., Zikic D., Nikolić A., Solajić S., Djordjević A., Bogdanović G.: Fullerenol C60 (OH) 24 effects on antioxidative enzymes activity in irradiated human erythroleukemia cell line. J. Radiat. Res., 2008;49:321-327
11. Bosi S., Da Ros T., Spalluto G., Prato M.: Fullerene derivatives: an attractive tool for biological applications. Eur. J. Med. Chem., 2003;38:913-923
12. Bourgier C., Levy A., Vozenin M. C., Deutsch E.: Pharmacological strategies to spare normal tissues from radiation damage: useless or overlooked therapeutics? Cancer Metastasis Rev., 2012;31:699-712
13. Brant J. A., Labille J., Robichaud C. O., Wiesner M.: Fullerol cluster formation in aqueous solutions: implications for environmental release. J. Colloid Interface Sci., 2007;314:281-288
14. Cagle D. W., Kennel S. J., Mirzadeh S., Alford J. M., Wilson L. J.: In vivo studies of fullerene-based materials using endohedral metallofullerene radiotracers. Proc. Natl. Acad. Sci. USA, 1999;96:5182-5187
15. Cai X., Hao J., Zhang X., Yu B., Ren J., Luo C., Li Q., Huang Q., Shi X., Li W., Liu J.: The polyhydroxylated fullerene derivative C60 (OH) 24 protects mice from ionizing-radiation-induced immune and mitochondrial dysfunction. Toxicol. Appl. Pharmacol., 2010;243:27-34
16. Cai X., Jia H., Liu Z., Hou B., Luo C., Feng Z., Li W., Liu J.: Polyhydroxylated fullerene derivative C60 (OH) 24 prevents mitochondrial dysfunction and oxidative damage in an MPP+-induced cellular model of Parkinson's disease. J. Neurosci. Res., 2008;86:3622-3634
17. Calissano P., Matrone C., Amadoro G.: Apoptosis and in vitro Alzheimer disease neuronal models. Commun. Integr. Biol., 2009;2:163-169
18. Chae S. R., Hotze E. M., Wiesner M. R.: Evaluation of the oxidation of organic compounds by aqueous suspensions of photosensitized hydroxylated-C60 fullerene aggregates. Environ. Sci. Technol., 2009;43:6208-6213
19. Chaudhuri P., Paraskar A., Soni S., Mashelkar R. A., Sengupta S.: Fullerenol-cytotoxic conjugates for cancer chemotherapy. ACS Nano, 2009;3:2505-2514
20. Chen Z., Ma K., Wang G., Zhao X., Tang A.: Structures and stabilities of C60 (OH) 4 and C60 (OH) 6 fullerenols. J. Mol. Struct. (Theochem), 2000;498:227-232
21. Chiang L. Y., Bhonsle J. B., Wang L., Shu S. F., Chang T. M., Hwu J. R.: Efficient one-flask synthesis of water-soluble [60]fullerenols. Tetrahedron, 1996;52:4963-4972
22. Chiang L. Y., Lu F. J., Lin J. T.: Free radical scavenging activity of watersoluble fullerenols. J. Chem. Soc. Chem. Commun., 1995;12:1283-1284
23. Chinta S. J., Andersen J. K.: Redox imbalance in Parkinson's disease. Biochim. Biophys. Acta, 2008;1780:1362-1367
24. Chirico F., Fumelli C., Marconi A., Tinari A., Straface E., Malorni W., Pellicciari R., Pincelli C.: Carboxyfullerenes localize within mitochondria and prevent the UVB-induced intrinsic apoptotic pathway. Exp. Dermatol., 2007;16:429-436
25. Choi J. S., Park J. C., Nah H., Woo S., Oh J., Kim K. M., Cheon G. J., Chang Y., Yoo J., Cheon J.: A hybrid nanoparticle probe for dual-modality positron emission tomography and magnetic resonance imaging. Angew. Chem. Int. Ed. Engl., 2008;47:6259-6262
26. Citrin D., Cotrim A. P., Hyodo F., Baum B. J., Krishna M. C., Mitchell J. B.: Radioprotectors and mitigators of radiation-induced normal tissue injury. Oncologist, 2010;15:360-371
27. Dauer W., Przedborski S.: Parkinson's disease: mechanisms and models. Neuron, 2003;39:889-909
28. Davie C. A.: A review of Parkinson's disease. Br. Med. Bull., 2008;86:109-127
29. Djordjević A., Ajdinovića B., Dopudjaa M., Trajkovića S., Milovanovića Z., Maksin T., Nešković O., Bogdanović G., Trpkov D., Cvetićanin J., Injac R.: Scintigraphy of the domestic dog using [99mTc (CO) 3 (H2O) 3]-C60 (OH) 22-24. Dig. J. Nanomater. Bios., 2010;6:99-106
30. Djordjevic A., Canadanovic-Brunet J., Vojinovic-Miloradov M., Bogdanovic G.: Antioxidant properties and hypothetical radical mechanism of fullerenol C60 (OH) 24. Oxid. Commun., 2005;27:806-812
31. Dragunow M., Faull R. L., Lawlor P., Beilharz E. J., Singleton K., Walker E. B., Mee E.: In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes. Neuroreport, 1995;6:1053-1057
32. Dringen R., Bishop G. M., Koeppe M., Dang T. N., Robinson S. R.: The pivotal role of astrocytes in the metabolism of iron in the brain. Neurochem. Res., 2007;32:1884-1890
33. Dugan L. L., Bruno V. M., Amagasu S. M., Giffard R. G.: Glia modulate the response of murine cortical neurons to excitotoxicity: glia exacerbate AMPA neurotoxicity. J. Neurosci., 1995;15:4545-4555
34. Dugan L. L., Gabrielsen J. K., Yu S. P., Lin T. S., Choi D. W.: Buckminsterfullerenol free radical scavengers reduce excitotoxic and apoptotic death of cultured cortical neurons. Neurobiol. Dis., 1996;3:129-135
35. Ehrich M., Van Tassell R., Li Y., Zhou Z., Kepley C. L.: Fullerene antioxidants decrease organophosphate-induced acetylcholinesterase inhibition in vitro. Toxicol. In Vitro, 2011;25:301-307
36. Fahn S., Cohen G.: The oxidant stress hypothesis in Parkinson's disease: evidence supporting it. Ann. Neurol., 1992;32:804-812
37. Fatouros P. P., Corwin F. D., Chen Z. J., Broaddus W. C., Tatum J. L., Kettenmann B., Ge Z., Gibson H. W., Russ J. L., Leonard A. P., Duchamp J. C., Dorn H. C.: In vitro and in vivo imaging studies of a new endohedral metallofullerene nanoparticle. Radiology, 2006;240:756-764
38. Foley S., Crowley C., Smaihi M., Bonfils C., Erlanger B. F., Seta P., Larroque C.: Cellular localisation of a water-soluble fullerene derivative. Biochem. Biophys. Res. Commun., 2002;294:116-119
39. Grȩbowski J., Krokosz A.: Fulereny w radiobiologii. Postȩpy Biochem., 2010;56:456-462
40. Grebowski J., Krokosz A., Puchala M.: Fullerenol C60 (OH) 36 could associate to band 3 protein of human erythrocyte membranes. Biochim. Biophys. Acta, 2013;1828:2007-2014
41. Grebowski J., Krokosz A., Puchala M.: Membrane fluidity and activity of membrane ATPases in human erythrocytes under the influence of polyhydroxylated fullerene. Biochim. Biophys. Acta, 2013;1828:241-248
42. Greenlund L. J., Deckwerth T. L., Johnson E. M. Jr.: Superoxide dismutase delays neuronal apoptosis: a role for reactive oxygen species in programmed neuronal death. Neuron, 1995;14:303-315
43. Grushko Y. S., Alekseev E. G., Kozlov V. S., Molkanov L. I., Wortmann G., Giefers H., Rupprecht K., Khodorkovskii M. A.: 161Dy Mössbauer study of the endohedral metallofullerenes Dy@Cn (n = 80, 82, 84). Hyperfine Interact., 2000;126:121-126
44. Guirado-López R. A., Rincón M. E.: Structural and optical properties of highly hydroxylated fullerenes: stability of molecular domains on the C60 surface. J. Chem. Phys., 2006;125:154312
45. Halliwell B., Gutteridge J.: Free Radicals in Biology and Medicine. Oxford Univ. Press. London, 3rd ed, 1999
46. Hirsch A. E., Rosenstein B. S., Medich D. C., Martel C. B., Hirsch J. A.: Polymethylmethacrylate and radioisotopes in vertebral augmentation: an explanation of underlying principles. Pain Physician, 2009;12:887-891
47. Hotze E. M., Bottero J. Y., Wiesner M. R.: Theoretical framework for nanoparticle reactivity as a function of aggregation state. Langmuir, 2010;26:11170-11175
48. Huang H. M., Ou H. C., Hsieh S. J., Chiang L. Y.: Blockage of amyloid beta peptide-induced cytosolic free calcium by fullerenol-1, carboxylate C60 in PC12 cells. Life Sci., 2000;66:1525-1533
49. Husebo L. O., Sitharaman B., Furukawa K., Kato T., Wilson L. J.: Fullerenols revisited as stable radical anions. J. Am. Chem. Soc., 2004;126:12055-12064
50. Icević I., Bogdanović V., Zikić D., Solajić S., Bogdanović G., Djordjević A.: The influence of fullerenol on the cell number, cell area, and colony forming unit ability in irradiated human erythroleukemic cell line. Hemijska Industrija, 2007;61:167-170
51. Injac R., Perse M., Cerne M., Potocnik N., Radic N., Govedarica B., Djordjevic A., Cerar A., Strukelj B.: Protective effects of fullerenol C60 (OH) 24 against doxorubicin-induced cardiotoxicity and hepatotoxicity in rats with colorectal cancer. Biomaterials, 2009;30:1184-1196
52. Injac R., Perse M., Obermajer N., Djordjevic-Milic V., Prijatelj M., Djordjevic A., Cerar A., Strukelj B.: Potential hepatoprotective effects of fullerenol C60 (OH) 24 in doxorubicin-induced hepatotoxicity in rats with mammary carcinomas. Biomaterials, 2008;29:3451-3460
53. Jeng U. S., Lin T. L., Chang T. S., Lee H. Y., Hsu C. H., Hsieh Y. W., Canteenwala T., Chiang L. Y.: Comparison of the aggregation behavior of water-soluble hexa (sulfobutyl) fullerenes and polyhydroxylated fullerenes for their free-radical scavenging activity. Prog. Colloid Polym. Sci., 2001;118:232-237
54. Jennings L. E., Long N. J.: 'Two is better than one' - probes for dualmodality molecular imaging. Chem. Commun., 2009;24:3511-3524
55. Jin H., Chen W. Q., Tang X. W., Chiang L. Y., Yang C. Y., Schloss J. V., Wu J. Y.: Polyhydroxylated C60, fullerenols, as glutamate receptor antagonists and neuroprotective agents. J. Neurosci. Res., 2000;62:600-607
56. Kato H., Kanazawa Y., Okumura M., Taninaka A., Yokawa T., Shinohara H.: Lanthanoid endohedral metallofullerenols for MRI contrast agents. J. Am. Chem. Soc., 2003;125:4391-4397
57. Kato S., Aoshima H., Saitoh Y., Miwa N.: Highly hydroxylated or γ-cyclodextrin-bicapped water-soluble derivative of fullerene: the antioxidant ability assessed by electron spin resonance method and β-carotene bleaching assay. Bioorg. Med. Chem. Lett., 2009;19:5293-5296
58. Kim J. E., Lee M.: Fullerene inhibits β-amyloid peptide aggregation. Biochem. Biophys. Res. Commun., 2003;303:576-579
59. Klaine S. J., Alvarez P. J., Batley G. E., Fernandes T. F., Handy R. D., Lyon D. Y., Mahendra S., McLaughlin M. J., Lead J. R.: Nanomaterials in the environment: behavior, fate, bioavailability, and effects. Environ. Toxicol. Chem., 2008;27:1825-1851
60. Kojić V., Jakimov D., Bogdanović G., Djordjević A.: Effects of fullerenol C60 (OH) 24 on cytotoxicity induced by antitumor drugs on human breast carcinoma cell lines. Mater. Sci. Forum, 2005;494:543-548
61. Kokubo K., Matsubayashi K., Tategaki H., Takada H., Oshima T.: Facile synthesis of highly water-soluble fullerenes more than half-covered by hydroxyl groups. ACS Nano, 2008;2:327-333
62. Komorowska M., Krokosz A., Szweda-Lewandowska Z.: Radiation damage to human erythrocytes: Influence of the composition of medium. Radiat. Phys. Chem., 2007;76:1587-1593
63. Kong L., Tedrow O., Chan Y. F., Zepp R. G.: Light-initiated transformations of fullerenol in aqueous media. Environ. Sci. Technol., 2009;43:9155-9160
64. Krantz A.: Red cell-mediated therapy: opportunities and challenges. Blood Cells Mol. Dis., 1997;23:58-68
65. Krokosz A.: Fulereny w biologii. Postȩpy Biochem., 2007;53:91-96
66. Krokosz A., Koziczak R., Gonciarz M., Szweda-Lewandowska Z.: Study of the effect of dose-rate on radiation-induced damage to human erythrocytes. Radiat. Phys. Chem., 2006;75:98-105
67. Krokosz A., Szweda-Lewandowska Z.: Changes in the activity of acetylcholinesterase and Na, K-ATPase in human erythrocytes irradiated with X-rays. Cell. Mol. Biol. Lett., 2005;10:471-478
68. Krusic P. J., Wasserman E., Keizer P. N., Morton J. R., Preston K. F.: Radical reactions of C60. Science, 1991;254:1183-1185
69. Lai H. S., Chen W. J., Chiang L. Y.: Free radical scavenging activity of fullerenol on the ischemia-reperfusion intestine in dogs. World J. Surg., 2000;24:450-454
70. Lai H. S., Chen Y., Chen W. J., Chang J., Chiang L. Y.: Free radical scavenging activity of fullerenol on grafts after small bowel transplantation in dogs. Transplant. Proc., 2000;32:1272-1274
71. Laus S., Sitharaman B., Tóth E., Bolskar R. D., Helm L., Asokan S., Wong M. S., Wilson L. J., Merbach A. E.: Destroying gadofullerene aggregates by salt addition in aqueous solution of Gd@C60 (OH) x and Gd@C60[C (COOH2)]10. J. Am. Chem. Soc., 2005;127:9368-9369
72. Lecoanet H. F., Bottero J. Y., Wiesner M. R.: Laboratory assessment of the mobility of nanomaterials in porous media. Environ. Sci. Technol., 2004;38:5164-5169
73. Lee C. M., Huang S. T., Huang S. H., Lin H. W., Tsai H. P., Wu J. Y., Lin C. M., Chen C. T.: C60 fullerene-pentoxifylline dyad nanoparticles enhance autophagy to avoid cytotoxic effects caused by the β-amyloid peptide. Nanomedicine, 2011;7:107-114
74. Li D., Fortner J. D., Johnson D. R., Chen C., Li Q., Alvarez P. J.: Bioaccumulation of 14C60 by the earthworm Eisenia fetida. Environ. Sci. Technol., 2010;44:9170-9175
75. Lotharius J., Dugan L. L., O'Malley K. L.: Distinct mechanisms underlie neurotoxin-mediated cell death in cultured dopaminergic neurons. J. Neurosci., 1999;19:1284-1293
76. Luo J., Wilson J. D., Zhang J., Hirsch J. I., Dorn H. C., Fatouros P. P., Shultz M. D.: A dual PET/MR imaging nanoprobe: 124I labeled Gd3N@C80. Appl. Sci., 2012;2:465-478
77. Maksin T., Djokic D., Jankovic D., Djordjevic A., Neskovic O.: Comparison of some physico-chemical parameters and biological behaviour of fullerenol labeled with technetium-99m. J. Optoelectr. Adv. Mater., 2007;9:2571-2577
78. Marczak A., Jóźwiak Z.: Damage to the cell antioxidative system in human erythrocytes incubated with idarubicin and glutaraldehyde. Toxicol. In Vitro, 2009;23:1188-1194
79. Markovic Z., Trajkovic V.: Biomedical potential of the reactive oxygen species generation and quenching by fullerenes (C60). Biomaterials, 2008;29:3561-3573
80. Marzatico F., Porta C., Moroni M., Bertorelli L., Borasio E., Finotti N., Pansarasa O., Castagna L.: In vitro antioxidant properties of amifostine (WR-2721, Ethyol). Cancer Chemother. Pharmacol., 2000;45:172-176
81. Menna P., Paz O. G., Chello M., Covino E., Salvatorelli E., Minotti G.: Anthracycline cardiotoxicity. Expert Opin. Drug Saf., 2012;11(Suppl. 1):S21-S36
82. Mikawa M., Kato H., Okumura M., Narazaki M., Kanazawa Y., Miwa N., Shinohara H.: Paramagnetic water-soluble metallofullerenes having the highest relaxivity for MRI contrast agents. Bioconjug. Chem., 2001;12:510-514
83. Milic V. D., Stankov K., Injac R., Djordjevic A., Srdjenovic B., Govedarica B., Radic N., Simic V. D., Strukelj B.: Activity of antioxidative enzymes in erythrocytes after a single dose administration of doxorubicin in rats pretreated with fullerenol C60 (OH) 24. Toxicol. Mech. Methods, 2009;19:24-28
84. Minotti G., Menna P., Salvatorelli E., Cairo G., Gianni L.: Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol. Rev., 2004;56:185-229
85. Mirkov S. M., Djordjevic A. N., Andric N. L., Andric S. A., Kostic T. S., Bogdanovic G. M., Vojinovic-Miloradov M. B., Kovacevic R. Z.: Nitric oxide-scavenging activity of polyhydroxylated fullerenol, C60 (OH) 24. Nitric Oxide, 2004;11:201-207
86. Nielsen G. D., Roursgaard M., Jensen K. A., Poulsen S. S., Larsen S. T.: In vivo biology and toxicology of fullerenes and their derivatives. Basic Clin. Pharmacol. Toxicol., 2008;103:197-208
87. Pacher P., Beckman J. S., Liaudet L.: Nitric oxide and peroxynitrite in health and disease. Physiol. Rev., 2007;87:315-424
88. Partha R., Conyers J. L.: Biomedical applications of functionalized fullerene-based nanomaterials. Int. J. Nanomedicine, 2009;4:261-275
89. Pia̧tek A., Dawid A., Gburski Z.: The properties of small fullerenol cluster (C60 (OH) 24) 7: computer simulation. Spectrochim Acta A Mol. Biomol. Spectrosc., 2011;79:819-823
90. Pickering K. D., Wiesner M. R.: Fullerol-sensitized production of reactive oxygen species in aqueous solution. Environ. Sci. Technol., 2005;39:1359-1365
91. Podolski I. Y., Podlubnaya Z. A., Godukhin O. V.: Fullerenes C60, antiamyloid action, the brain and cognitive processes. Biofizika, 2010;55:88-94
92. Podolski I. Y., Podlubnaya Z. A., Kosenko E. A., Mugantseva E. A., Makarova E. G., Marsagishvili L. G., Shpagina M. D., Kaminsky Y. G., Andrievsky G. V., Klochkov V. K.: Effects of hydrated forms of C60 fullerene on amyloid 1-peptide fibrillization in vitro and performance of the cognitive task. J. Nanosci. Nanotechnol., 2007;7:1479-1485
93. Qingnuan L., Yan X., Xiaodong Z., Ruili L., Qianqian D., Xiaoguang S., Shaoliang C., Wenxin L.: Biodistribution of fullerene derivative C60 (OH) x (O) y. Chin. Sci. Bull., 2001;46:1615-1617
94. Qingnuan L., Yan X., Xiaodong Z., Ruili L., Qieqie D., Xiaoguang S., Shaoliang C., Wenxin L.: Preparation of 99mTc-C60 (OH) x and its biodistribution studies. Nucl. Med. Biol., 2002;29:707-710
95. Reiter R. J.: Oxidative processes and antioxidative defense mechanisms in the aging brain. FASEB J., 1995;9:526-533
96. Saitoh Y., Mizuno H., Xiao L., Hyoudou S., Kokubo K., Miwa N.: Polyhydroxylated fullerene C60 (OH) 44 suppresses intracellular lipid accumulation together with repression of intracellular superoxide anion radicals and subsequent PPARγ2 expression during spontaneous differentiation of OP9 preadipocytes into adipocytes. Mol. Cell. Biochem., 2012;366:191-200
97. Schreiner K. M., Filley T. R., Blanchette R. A., Bowen B. B., Bolskar R. D., Hockaday W. C., Masiello C. A., Raebiger J. W.: White-rot basidiomycete-mediated decomposition of C60 fullerol. Environ. Sci. Technol., 2009;43:3162-3168
98. Socoowski Britto R., Garcia M. L., Martins da Rocha A., Flores J. A., Pinheiro M. V., Monserrat J. M., Ferreira J. L.: Effects of carbon nanomaterials fullerene C60 and fullerol C60 (OH) 18-22 on gills of fish Cyprinus carpio (Cyprinidae) exposed to ultraviolet radiation. Aquat. Toxicol., 2012;114-115:80-87
99. Srdjenovic B., Milic-Torres V., Grujic N., Stankov K., Djordjevic A., Vasovic V.: Antioxidant properties of fullerenol C60 (OH) 24 in rat kidneys, testes, and lungs treated with doxorubicin. Toxicol. Mech. Methods, 2010;20:298-305
100. Szuławska A., Czyż M.: Molekularne mechanizmy działania antracyklin. Postȩpy Hig. Med. Dośw., 2006;60:78-100
101. * radicals: molecular changes in erythrocyte membranes. Free Radic. Res., 2003;37:1137-1143
102. Tabaczar S., Talar M., Gwoździński K.: Nitroksydy jako antyoksydanty - możliwości ich zastosowania w celach chemioprewencyjnych oraz radioprotekcyjnych. Postȩpy Hig. Med. Dośw., 2011;65:46-54
103. Torres V. M., Srdjenovic B., Jacevic V., Simic V. D., Djordjevic A., Simplício A. L.: Fullerenol C60 (OH) 24 prevents doxorubicin-induced acute cardiotoxicity in rats. Pharmacol. Rep., 2010;62:707-718
104. Trajković S., Dobric S., Djordjević A., Dragojevic-Simic V., Milovanovic Z.: Radioprotective efficiency of fullerenol in irradiated mice. Mater. Sci. Forum, 2005;494:549-554
105. Trajković S., Dobrić S., Jaćević V., Dragojević-Simić V., Milovanović Z., Dordević A.: Tissue-protective effects of fullerenol C60 (OH) 24 and amifostine in irradiated rats. Colloids Surf. B Biointerfaces, 2007;58:39-43
106. Tsai M. C., Chen Y. H., Chiang L. Y.: Polyhydroxylated C60, fullerenol, a novel free-radical trapper, prevented hydrogen peroxide- and cumene hydroperoxide-elicited changes in rat hippocampus in-vitro. J. Pharm. Pharmacol., 1997;49:438-445
107. Uppal R., Catana C., Ay I., Benner T., Sorensen A. G., Caravan P.: Bimodal thrombus imaging: simultaneous PET/MR imaging with a fibrin-targeted dual PET/MR probe - feasibility study in rat model. Radiology, 2011;258:812-820
108. Vileno B., Marcoux P. R., Lekka M., Sienkiewicz A., Fehér T., Forró L.: Spectroscopic and photophysical properties of a highly derivatized C60 fullerol. Adv. Funct. Mater., 2006;16:120-128
109. Vileno B., Sienkiewicz A., Lekka M., Kulik A. J., Forró L.: In vitro assay of singlet oxygen generation in the presence of water-soluble derivatives of C60. Carbon, 2004;42:1195-1198
110. White A. R., Bush A. I.: The metallobiology of Alzheimer's disease: from bench to clinic. CML Neurology, 2006;22:89-97
111. Wilson L. J., Cagle D. W., Thrash T. P., Kennel S. J., Mirzadeh S., Alford J. M., Ehrhardt G. J.: Metallofullerene drug design. Coord. Chem. Rev., 1999;190-192:199-207
112. Xiao L., Aoshima H., Saitoh Y., Miwa N.: Highly hydroxylated fullerene localizes at the cytoskeleton and inhibits oxidative stress in adipocytes and a subcutaneous adipose-tissue equivalent. Free Radic. Biol. Med., 2011;51:1376-1389
113. Xiao L., Takada H., Gan X., Miwa N.: The water-soluble fullerene derivative "Radical Sponge" exerts cytoprotective action against UVA irradiation but not visible-light-catalyzed cytotoxicity in human skin keratinocytes. Bioorg. Med. Chem. Lett., 2006;16:1590-1595
114. Xiao L., Takada H., Maeda K., Haramoto M., Miwa N.: Antioxidant effects of water-soluble fullerene derivatives against ultraviolet ray or peroxylipid through their action of scavenging the reactive oxygen species in human skin keratinocytes. Biomed. Pharmacother., 2005;59:351-358
115. Xu J. Y., Su Y. Y., Cheng J. S., Li S. X., Liu R., Li W. X., Xu G. T., Li Q. N.: Protective effects of fullerenol on carbon tetrachloride-induced acute hepatotoxicity and nephrotoxicity in rats. Carbon, 2010;48:1388-1396
116. Yin J. J., Lao F., Fu P. P., Wamer W. G., Zhao Y., Wang P. C., Qiu Y., Sun B., Xing G., Dong J., Liang X. J., Chen C.: The scavenging of reactive oxygen species and the potential for cell protection by functionalized fullerene materials. Biomaterials, 2009;30:611-621
117. Zajdel A., Wilczok A., Slowinski J., Orchel J., Mazurek U.: Aldehydic lipid peroxidation products in human brain astrocytomas. J. Neurooncol., 2007;84:167-173
118. Zha Y. Y., Yang B., Tang M. L., Guo Q. C., Chen J. T., Wen L. P., Wang M.: Concentration-dependent effects of fullerenol on cultured hippocampal neuron viability. Int. J. Nanomedicine, 2012;7:3099-3109
119. Zhang G., Liu Y., Liang D., Gan L., Li Y.: Facile synthesis of isomerically pure fullerenols and formation of spherical aggregates from C60 (OH) 8. Angew. Chem. Int. Ed. Engl., 2010;49:5293-5295
120. Zhang J., Fatouros P. P., Shu C., Reid J., Owens L. S., Cai T., Gibson H. W., Long G. L., Corwin F. D., Chen Z. J., Dorn H. C.: High relaxivity trimetallic nitride (Gd3N) metallofullerene MRI contrast agents with optimized functionality. Bioconjug. Chem., 2010;21:610-615
121. Zhao Q., Li Y., Xu J., Liu R., Li W.: Radioprotection by fullerenols of Stylonychia mytilus exposed to γ-rays. Int. J. Radiat. Biol., 2005;81:169-175